Hospital de la Santa Creu i Sant Pau at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Hospital de la Santa Creu i Sant Pau takes part in 5 sessions at ESMO 2026 in Madrid. Its program centres on lung cancer, from KRAS G12C-mutant early stage disease and immunotherapy in frail older patients to managing side effects of antibody-drug conjugate combinations. Other sessions cover enfortumab vedotin in urothelial carcinoma and desmoid tumours, including the patient's lived experience.

Organization

ESMO 2026 Attendance

Hospital de la Santa Creu i Sant Pau

Barcelona, Spain

santpau.cat

Cancer centre & hospital

University hospital in Barcelona, Spain, affiliated with the Autonomous University of Barcelona.

Abstract

Sat Oct 24
10:50–10:55

4740RO - Enfortumab Vedotin (EV) With or Without Pembrolizumab (P) as First-Line (1L) Treatment for Cisplatin (cis)-Ineligible Locally Advanced Or Metastatic Urothelial Carcinoma (la/mUC): Long-Term Follow-up Analysis from EV-103 Cohorts DE/A and K

Rapid oral 1: Genitourinary tumours, renal and urothelial

Genitourinary cancers

Satellite

Sat Oct 24
13:45–14:05

KRAS G12C in Early-Stage NSCLC: Can We Do Better?

Eli Lilly and Company - KRAS G12C-Mutant NSCLC Across the Disease Continuum: From Biology and Unmet Needs to Optimizing Care

Lung & thoracic cancers

Satellite

Sun Oct 25
10:55–11:05

Managing overlapping toxicities with ADC-based combination therapies - Identification and practical management of AEs with ADC-based combination therapies

AstraZeneca - On the frontlines: Optimizing ADC patient care in lung cancer

Lung & thoracic cancersNursing & supportive care

Satellite

Sun Oct 25
11:05–11:35

Applying multidisciplinary approaches to real-world scenarios - Case study presentation followed by moderated group discussion and Q&A

AstraZeneca - On the frontlines: Optimizing ADC patient care in lung cancer · with Beaumont Hospital, Jessa Hospital, Henry Dunant Hospital Center

Lung & thoracic cancersNursing & supportive care

Satellite

Mon Oct 26
13:00–14:30

Merck Healthcare KGaA - CARE FOR RARE: Desmoid Tumours in Clinical Practice − Shifting Strategies & Evolving Perspectives

with University Medical Centre Mannheim

Sarcoma, CNS, head & neck and rare cancers

Satellite

Mon Oct 26
13:00–13:05

Welcome

Merck Healthcare KGaA - CARE FOR RARE: Desmoid Tumours in Clinical Practice − Shifting Strategies & Evolving Perspectives

Sarcoma, CNS, head & neck and rare cancers

Satellite

Mon Oct 26
13:35–13:50

Mapping the Role of Immunotherapy in Frail and Elderly Patients

F. Hoffmann - La Roche LTD - Advancing the Frontiers of Lung Cancer Care

Lung & thoracic cancers

Satellite

Mon Oct 26
13:50–14:15

Shifting Paradigms in ES-SCLC and the Next Wave of ADCs in Lung Cancer

F. Hoffmann - La Roche LTD - Advancing the Frontiers of Lung Cancer Care · with Georgetown Lombardi Comprehensive Cancer Center

Lung & thoracic cancers

Satellite

Mon Oct 26
14:00–14:20

The lived experience: Two voices, one journey

Merck Healthcare KGaA - CARE FOR RARE: Desmoid Tumours in Clinical Practice − Shifting Strategies & Evolving Perspectives · with Italian Desmoid Foundation

Sarcoma, CNS, head & neck and rare cancers

Instantly find 20 buyers from Hospital de la Santa Creu i Sant Pau

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction